Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Feb 22, 2017 9:19am
291 Views
Post# 25876257

RE:RE:RBC

RE:RE:RBC
1wascallywabbit wrote: Exactly what I said.....November data showed improvement, this data shows stabilization but no improvement. For that I get shyt on, and then RBC sees the same thing. Go figure. LOL.


Go look at the chart Wabbit and tell me where you see the purple line trending.... Ask yourself, if you have IPF, do you want to take the $8 Billion approved drug that still results in decreasing lung function, or 4050 that results in AT WORST stable lung function?!?!? Seems like a very simple choice to me.
Bullboard Posts